Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-06-20
2011-11-29
Nolan, Jason M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S213000
Reexamination Certificate
active
08067452
ABSTRACT:
This invention provides compounds of Formula I which are inhibitors of Chk2 and are useful as a radiation protection agents in anticancer radiotherapy. A method of modulating Chk2 in vitro includes treating a substrate with Chk2 in the presence of compounds of formula I. A method of making a compound of formula I includes: a) forming a biaryl amine having an amino (NH2) group; b) converting the amino group to an isothiocyanate group; c) adding a cyanoacetamide to the isothiocyanate group to form a thioamide adduct; d) cyclizing the thioamide adduct to form an isothiazole having a cyano group; and e) adding an amine to the cyano group to form a carboxamidine group.
REFERENCES:
patent: 7429667 (2008-09-01), Abdellaoui et al.
patent: 7652047 (2010-01-01), Abdellaoui et al.
El Abdellaoui et al. Bioorganic & Medicinal Chem. Lett. 2006, 16(21), 5561-66.
Carlessi et al. Molecular Cancer Therapeutics 2007, 6(3), 935-44.
Larson, et al., “Identification of novel, selective and potent Chk2 inhibitors,”Bioorganic&Med. Chem Ltrs12:172-175 (2007).
Chen Huanming
Wu Jim Zhen
Jones Day
Nolan Jason M
Valeant Pharmaceuticals International
LandOfFree
3-hydroxyisothiazole-4-carboxamidine derivatives as CHK2... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-hydroxyisothiazole-4-carboxamidine derivatives as CHK2..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-hydroxyisothiazole-4-carboxamidine derivatives as CHK2... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4290897